149 related items for PubMed ID: 3491830
1. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression.
Kaye WH, Gwirtsman HE, George DT, Ebert MH, Jimerson DC, Tomai TP, Chrousos GP, Gold PW.
J Clin Endocrinol Metab; 1987 Feb; 64(2):203-8. PubMed ID: 3491830
[Abstract] [Full Text] [Related]
2. The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients.
Hotta M, Shibasaki T, Masuda A, Imaki T, Demura H, Ling N, Shizume K.
J Clin Endocrinol Metab; 1986 Feb; 62(2):319-24. PubMed ID: 3001125
[Abstract] [Full Text] [Related]
3. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients.
Gold PW, Gwirtsman H, Avgerinos PC, Nieman LK, Gallucci WT, Kaye W, Jimerson D, Ebert M, Rittmaster R, Loriaux DL.
N Engl J Med; 1986 May 22; 314(21):1335-42. PubMed ID: 3010109
[Abstract] [Full Text] [Related]
4. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP.
Adv Biochem Psychopharmacol; 1987 May 22; 43():183-200. PubMed ID: 3035886
[Abstract] [Full Text] [Related]
5. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ, May C, Post RM, Chrousos GP, Gold PW.
J Clin Endocrinol Metab; 1991 Feb 22; 72(2):260-71. PubMed ID: 1846869
[Abstract] [Full Text] [Related]
6. CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic pituitary-adrenal cortical axis.
Kaye WH, Rubinow D, Gwirtsman HE, George DT, Jimerson DC, Gold PW.
Psychoneuroendocrinology; 1988 Feb 22; 13(3):265-72. PubMed ID: 2900533
[Abstract] [Full Text] [Related]
7. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.
Geracioti TD, Loosen PT, Orth DN.
Biol Psychiatry; 1997 Aug 01; 42(3):165-74. PubMed ID: 9232208
[Abstract] [Full Text] [Related]
8. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.
Kling MA, Rubinow DR, Doran AR, Roy A, Davis CL, Calabrese JR, Nieman LK, Post RM, Chrousos GP, Gold PW.
Neuroendocrinology; 1993 Jan 01; 57(1):79-88. PubMed ID: 8097579
[Abstract] [Full Text] [Related]
9. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC.
J Psychiatr Res; 2007 Jan 01; 41(1-2):131-43. PubMed ID: 16455105
[Abstract] [Full Text] [Related]
10. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain.
Mantzoros C, Flier JS, Lesem MD, Brewerton TD, Jimerson DC.
J Clin Endocrinol Metab; 1997 Jun 01; 82(6):1845-51. PubMed ID: 9177394
[Abstract] [Full Text] [Related]
11. CSF corticotropin-releasing hormone in depressed patients and normal control subjects.
Roy A, Pickar D, Paul S, Doran A, Chrousos GP, Gold PW.
Am J Psychiatry; 1987 May 01; 144(5):641-5. PubMed ID: 3495188
[Abstract] [Full Text] [Related]
12. Contribution of CNS neuropeptide (NPY, CRH, and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa.
Kaye WH, Berrettini WH, Gwirtsman HE, Gold PW, George DT, Jimerson DC, Ebert MH.
Psychopharmacol Bull; 1989 May 01; 25(3):433-8. PubMed ID: 2533990
[Abstract] [Full Text] [Related]
13. Cerebrospinal fluid TRH immunoreactivity in anorexia nervosa.
Lesem MD, Kaye WH, Bissette G, Jimerson DC, Nemeroff CB.
Biol Psychiatry; 1994 Jan 01; 35(1):48-53. PubMed ID: 8167204
[Abstract] [Full Text] [Related]
14. Cerebrospinal Fluid CRH Levels in Late Pregnancy Are Not Associated With New-Onset Postpartum Depressive Symptoms.
Zaconeta AM, Amato AA, Barra GB, Casulari da Motta LD, de Souza VC, Karnikowski MG, Casulari LA.
J Clin Endocrinol Metab; 2015 Aug 01; 100(8):3159-64. PubMed ID: 26066672
[Abstract] [Full Text] [Related]
15. Corticotropin-releasing hormone: possible role in eating disorders.
Krahn DD, Gosnell BA.
Psychiatr Med; 1989 Aug 01; 7(4):235-45. PubMed ID: 2690192
[Abstract] [Full Text] [Related]
16. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.
Geracioti TD, Orth DN, Ekhator NN, Blumenkopf B, Loosen PT.
J Clin Endocrinol Metab; 1992 Jun 01; 74(6):1325-30. PubMed ID: 1317385
[Abstract] [Full Text] [Related]
17. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.
Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, Geracioti TD, DeBellis MD, Rice KC, Goldstein DS, Veldhuis JD, Chrousos GP, Oldfield EH, McCann SM, Gold PW.
Proc Natl Acad Sci U S A; 2000 Jan 04; 97(1):325-30. PubMed ID: 10618417
[Abstract] [Full Text] [Related]
18. Diurnal variation of cerebrospinal fluid immunoreactive corticotropin-releasing hormone levels in healthy volunteers.
Kling MA, DeBellis MD, O'Rourke DK, Listwak SJ, Geracioti TD, McCutcheon IE, Kalogeras KT, Oldfield EH, Gold PW.
J Clin Endocrinol Metab; 1994 Jul 04; 79(1):233-9. PubMed ID: 8027234
[Abstract] [Full Text] [Related]
19. Corticotropin-releasing hormone: from endocrinology to psychobiology.
Smith MA, Kling MA, Whitfield HJ, Brandt HA, Demitrack MA, Geracioti TD, Chrousos GP, Gold PW.
Horm Res; 1989 Jul 04; 31(1-2):66-71. PubMed ID: 2656470
[Abstract] [Full Text] [Related]
20. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence.
Adinoff B, Anton R, Linnoila M, Guidotti A, Nemeroff CB, Bissette G.
Neuropsychopharmacology; 1996 Sep 04; 15(3):288-95. PubMed ID: 8873112
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
